Artelo Biosciences, Inc.
ARTL
$9.35
-$0.18-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 176.94% | -68.09% | -51.86% | -13.30% | -26.38% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.23% | -3.20% | 69.77% | -77.21% | -2.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.58% | -45.95% | -48.72% | -19.16% | -24.67% |
|
|
|||||
| Total Current Assets | 61.58% | -45.95% | -48.72% | -19.16% | -24.67% |
| Net Property, Plant & Equipment | -9.89% | -8.08% | -8.33% | -6.90% | -6.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 23.95% | -25.18% | -34.16% | -14.29% | -19.59% |
|
|
|||||
| Total Accounts Payable | 92.95% | 49.43% | 167.78% | -27.35% | 42.17% |
| Total Accrued Expenses | 91.30% | -62.30% | 69.44% | -18.18% | -46.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 2.86% | 2.94% | 3.03% | 6.45% |
| Total Finance Division Other Current Liabilities | -- | 7,966.67% | -- | -- | -- |
| Total Other Current Liabilities | -- | 7,966.67% | -- | -- | -- |
| Total Current Liabilities | 103.71% | 58.24% | 154.23% | -25.85% | 30.37% |
|
|
|||||
| Total Current Liabilities | 103.71% | 58.24% | 154.23% | -25.85% | 30.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.56% | -14.49% | -11.54% | -10.34% | -9.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 101.29% | 55.51% | 137.55% | -24.54% | 25.70% |
|
|
|||||
| Common Stock & APIC | 2.31% | 0.36% | 0.49% | 0.40% | 0.37% |
| Retained Earnings | -6.13% | -4.73% | -8.15% | -2.50% | -5.69% |
| Treasury Stock & Other | -29.96% | -12.38% | 7.34% | -7.39% | 0.00% |
| Total Common Equity | -315.64% | -77.18% | -55.09% | -12.85% | -23.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -315.64% | -77.18% | -55.09% | -12.85% | -23.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -315.64% | -77.18% | -55.09% | -12.85% | -23.47% |
|
|
|||||